BioForce Nanosciences Holdings, Inc.
BFNH
$1.63
$0.1812.41%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 600.00 | 700.00 | 700.00 | 700.00 | 700.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 600.00 | 700.00 | 700.00 | 700.00 | 700.00 |
|
|
|||||
| Total Current Assets | 600.00 | 700.00 | 700.00 | 700.00 | 700.00 |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 600.00 | 700.00 | 700.00 | 700.00 | 700.00 |
|
|
|||||
| Total Accounts Payable | 2.60K | 1.10K | 1.10K | 1.60K | 400.00 |
| Total Accrued Expenses | 1.60M | 1.49M | 1.39M | 1.28M | 1.17M |
| Short-term Debt | 220.70K | 213.70K | 205.70K | 197.10K | 174.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.82M | 1.71M | 1.59M | 1.48M | 1.35M |
|
|
|||||
| Total Current Liabilities | 1.82M | 1.71M | 1.59M | 1.48M | 1.35M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 220.70K | 213.70K | 205.70K | 197.10K | 174.10K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.82M | 1.71M | 1.59M | 1.48M | 1.35M |
|
|
|||||
| Common Stock & APIC | 158.81M | 158.81M | 158.81M | 158.81M | 158.81M |
| Retained Earnings | -160.63M | -160.52M | -160.40M | -160.29M | -160.16M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.82M | -1.70M | -1.59M | -1.48M | -1.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.82M | -1.70M | -1.59M | -1.48M | -1.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.82M | -1.70M | -1.59M | -1.48M | -1.35M |
|
|
|||||
